Honest Criticisms and Limitations of the SURMOUNT-2 Trial
A deep-dive into the enrollment biases, generalizability gaps, statistical caveats, and conflict-of-interest issues in the SURMOUNT-2 trial of tirzepatide for weight loss in type 2 diabetes.
Trials Surmount 2
7 source-based articles maintained by the HealthRX.com Editorial Team.
7articles
2topic areas covered
May 25, 2026latest review
Trials Surmount 2 library
Showing 7 of 7 clinical reviews.
Inside the SURMOUNT-2 Methodology: What Most Summaries Skip
A deep-dive into the SURMOUNT-2 trial design, randomization, estimand framework, and statistical choices that shaped tirzepatide's weight-loss results in type 2 diabetes.
SURMOUNT-2 Extension Data and What Happened After the Trial Ended
Deep-dive into SURMOUNT-2 follow-up and extension findings for tirzepatide in type 2 diabetes, covering durability of weight loss, weight regain after discontinuation, and long-term safety signals.
SURMOUNT-2 Results in Detail: Numbers, Subgroups, and Time Course
A deep-dive into the SURMOUNT-2 trial results for tirzepatide in type 2 diabetes, covering primary and secondary endpoints, effect sizes, confidence intervals, response distributions, and the weekly weight-loss trajectory.
SURMOUNT-2 Subgroup Analyses: Who Responded Most and Least
Deep-dive into SURMOUNT-2 pre-specified and post-hoc subgroup analyses for tirzepatide in type 2 diabetes: responses by age, sex, BMI, race, and baseline biomarkers.
SURMOUNT-2 Trial: A Plain-English Overview of What It Established
A clear, evidence-based overview of the SURMOUNT-2 trial, which tested tirzepatide for weight loss in adults with type 2 diabetes and obesity. Covers study design, key results, limitations, and clinical relevance.
What SURMOUNT-2 Actually Changes in Clinical Practice
A deep-dive into the SURMOUNT-2 trial of tirzepatide in type 2 diabetes, examining which guidelines shifted, how prescribing patterns changed, and what the results mean for real-world patients.